0001019687-14-000551.txt : 20140214 0001019687-14-000551.hdr.sgml : 20140214 20140214162359 ACCESSION NUMBER: 0001019687-14-000551 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140214 DATE AS OF CHANGE: 20140214 EFFECTIVENESS DATE: 20140214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN ORIENTAL BIOENGINEERING INC CENTRAL INDEX KEY: 0001090514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911948329 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-141882 FILM NUMBER: 14617052 BUSINESS ADDRESS: STREET 1: NO, 4018 JINTIAN ROAD, ANLIAN PLAZA STREET 2: 12F SUITE B02 CITY: FUTIAN, DISTRICT SHENZHEN STATE: F4 ZIP: 518026 BUSINESS PHONE: 86-451-8666-6601 MAIL ADDRESS: STREET 1: NO, 4018 JINTIAN ROAD, ANLIAN PLAZA STREET 2: 12F SUITE B02 CITY: FUTIAN, DISTRICT SHENZHEN STATE: F4 ZIP: 518026 FORMER COMPANY: FORMER CONFORMED NAME: ORIENTAL BIOENGINEERING INC DATE OF NAME CHANGE: 19990824 S-8 POS 1 aob_s8posam-141882.htm POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8

As filed with the Securities and Exchange Commission on February 14, 2014

Registration No. 333-141882

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

AMERICAN ORIENTAL BIOENGINEERING, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

84-0605867

(State or other jurisdiction of incorporation or organization) I.R.S. Employer Identification No.

 

1 Liangshuihe First Ave, Beijing E-Town
Economic and Technology Development Area, E-Town
Beijing, 100176, People’s Republic of China

(Address of Principal Executive Offices) (Zip Code)

 

American Oriental Bioengineering, Inc.
2006 Equity Incentive Plan

(Full title of the plan)

 

L and R Service Company of Nevada, LLC
3993 Howard Hughes Pkwy Ste. 600
Las Vegas, NV 89169

702.949.8200

 

(Name and address of agent for service)

 

+ 86-10-5982-2039

(Telephone number, including area code, of agent for service)

 

Copies of all communications, including all communications sent to agent for service, to:

 

Mitchell S. Nussbaum, Esq.
Loeb & Loeb LLP
345 Park Avenue
New York, NY 10154
Tel. No. 212-407-4159 Fax No. 212-407-4990

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer [_] Accelerated Filer [_]

Non-Accelerated Filer [_]

(Do not check if a smaller reporting company)

 Smaller Reporting Company [X]

  

 
 

 

EXPLANATORY NOTE

 

 

DEREGISTRATION OF SECURITIES

 

American Oriental Bioengineering, Inc. (the “Company”) is filing this Post-Effective Amendment No. 1 to its registration statement on Form S-8 (File No. 333-141882), filed on April 4, 2007 (the “Registration Statement”), pertaining to the Company’s registration of 5,000,000 shares of common stock, which are issued or issuable under the Company’s 2006 Equity Incentive Plan.

 

On February 14, 2014, the Company filed Amendment No. 3 to Schedule 13E-3 as part of a “going private” transaction structured to permit the Company to discontinue its reporting obligations under the Securities Exchange Act of 1934. In furtherance of that objective, and pursuant to the undertaking made by the Company in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering, the Company is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister all of the securities that remain unsold under the Registration Statement.

 

 

 

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Beijing, in The People’s Republic of China, on the 14th day of February 2014.

 

  AMERICAN ORIENTAL BIOENGINEERING
     
  By: /s/ Tony Liu
    Tony Liu
    Chief Executive Officer

 

 

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Tony Liu, individually, his true and lawful attorney-in-fact, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments including post-effective amendments to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact or his substitute, each acting alone, may lawfully do or cause to be done by virtue thereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

 

Name   Position   Date  
           
/s/ Tony Liu   Chairman and CEO (Principal Executive   February 14, 2014  
Tony Liu   Officer) and Director      
           
/s/ Yanchun Li   Chief Financial Officer (Principal Financial Officer) and Director   February 14, 2014  
Yanchun Li          
           
/s/ Jun Min   Director   February 14, 2014  
Jun Min          
           
/s/ Gao Yan   Chief Accounting Officer   February 14, 2014  
Gao Yan          
           
/s/ Cosimo Patti   Director   February 14, 2014  
Cosimo Patti          
           
/s/ Xianmin Wang   Director   February 14, 2014  
Xianmin Wang          
           
/s/ Baiqing Zhang   Director   February 14, 2014  
Baiqing Zhang          
           

 

 

 

 

3